Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O. Cherry BM, et al. Among authors: manasanch ee. Leuk Lymphoma. 2013 Oct;54(10):2215-8. doi: 10.3109/10428194.2013.764419. Epub 2013 Jul 29. Leuk Lymphoma. 2013. PMID: 23311294 Free PMC article.
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Kwak L, Szymura S, Wang L, Zhang T, Cha SC, Dong Z, Anderson A, Oh E, Lee V, Wang Z, Parshottham S, Rao S, Olsem J, Crumpton B, Lee H, Manasanch E, Neelapu S, Thomas S. Kwak L, et al. Res Sq [Preprint]. 2023 Sep 21:rs.3.rs-3315017. doi: 10.21203/rs.3.rs-3315017/v1. Res Sq. 2023. Update in: Nat Commun. 2024 Aug 11;15(1):6874. doi: 10.1038/s41467-024-50880-2 PMID: 37790486 Free PMC article. Updated. Preprint.
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Manasanch EE, Braylan R, Stetler-Stevenson M, Yuan C, Gounden V, Korde N, Tageja N, Bhutani M, Calvo K, Maric I, Roschewski M, Staudt LM, Landgren O. Manasanch EE, et al. Leuk Lymphoma. 2014 Jun;55(6):1402-3. doi: 10.3109/10428194.2013.831091. Epub 2013 Dec 2. Leuk Lymphoma. 2014. PMID: 23915224 Free PMC article. No abstract available.
Smoldering multiple myeloma: present position and potential promises.
Tageja N, Manasanch EE, Korde N, Kwok M, Mailankody S, Bhutani M, Roschewski M, Landgren O. Tageja N, et al. Among authors: manasanch ee. Eur J Haematol. 2014 Jan;92(1):1-12. doi: 10.1111/ejh.12205. Epub 2013 Nov 26. Eur J Haematol. 2014. PMID: 24112232 Review.
Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease.
Zingone A, Wang W, Corrigan-Cummins M, Wu SP, Plyler R, Korde N, Kwok M, Manasanch EE, Tageja N, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Roschewski M, Zhang Y, Roccaro AM, Ghobrial IM, Calvo KR, Landgren O. Zingone A, et al. Among authors: manasanch ee. Cytokine. 2014 Oct;69(2):294-7. doi: 10.1016/j.cyto.2014.05.017. Epub 2014 Jul 17. Cytokine. 2014. PMID: 25043675 Free PMC article.
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method.
Manasanch EE, Salem DA, Yuan CM, Tageja N, Bhutani M, Kwok M, Kazandjian D, Carter G, Steinberg SM, Zuchlinski D, Mulquin M, Calvo K, Maric I, Roschewski M, Korde N, Braylan R, Landgren O, Stetler-Stevenson M. Manasanch EE, et al. Leuk Lymphoma. 2015 May;56(5):1416-24. doi: 10.3109/10428194.2014.955020. Epub 2014 Oct 30. Leuk Lymphoma. 2015. PMID: 25263319 Free PMC article.
91 results